{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T16:21:54Z","timestamp":1777134114166,"version":"3.51.4"},"reference-count":185,"publisher":"Elsevier","isbn-type":[{"value":"9780128177402","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.pmbts.2019.03.005","type":"book-chapter","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T07:16:33Z","timestamp":1553584593000},"page":"487-522","source":"Crossref","is-referenced-by-count":29,"title":["Clinical applications of the naturally occurring or synthetic glycosylated low molecular weight drugs"],"prefix":"10.1016","author":[{"given":"Jing","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrd1343","article-title":"Small-molecule inhibitors of protein-protein interactions: progressing towards the dream","volume":"3","author":"Arkin","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.chembiol.2013.09.010","article-title":"Glycotherapy: new advances inspire a reemergence of glycans in medicine","volume":"21","author":"Hudak","year":"2014","journal-title":"Chem Biol"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0020","series-title":"Essentials of Glycobiology","article-title":"Glycans in biotechnology and the pharmaceutical industry","author":"Bertozzi","year":"2009"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.03.005_bb0025","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2174\/1568026614666140423103848","article-title":"Enantioselective synthesis in carbohydrate-based drug discovery: imino sugars, alkaloids and macrolide antibiotics","volume":"14","author":"Xavier","year":"2014","journal-title":"Curr Top Med Chem"},{"issue":"437","key":"10.1016\/bs.pmbts.2019.03.005_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.blo.0000175887.98112.fe","article-title":"Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria","volume":"2005","author":"Schatz","year":"1944","journal-title":"Clin Orthop Relat Res"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.03.005_bb0035","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1592\/phco.21.13.1037.34625","article-title":"Population pharmacokinetics of intravenous and intramuscular streptomycin in patients with tuberculosis","volume":"21","author":"Zhu","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.03.005_bb0040","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/thx.2009.131532","article-title":"Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis","volume":"65","author":"Prayle","year":"2010","journal-title":"Thorax"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2019.03.005_bb0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clinbiochem.2012.10.031","article-title":"Streptomycin interference in Jaffe reaction\u2014possible false positive creatinine estimation in excessive dose exposure","volume":"46","author":"Syal","year":"2013","journal-title":"Clin Biochem"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.03.005_bb0050","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/cid\/cir197","article-title":"Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases","volume":"52","author":"Tangden","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.03.005_bb0055","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0194599814565594","article-title":"Attenuation of streptomycin ototoxicity by tetramethylpyrazine in guinea pig cochlea","volume":"152","author":"Cui","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"08","key":"10.1016\/bs.pmbts.2019.03.005_bb0060","first-page":"983","article-title":"Analysis of adverse reactions of aminoglycoside antibiotics","volume":"22","author":"Fan","year":"2011","journal-title":"J Aerosp Med"},{"issue":"23","key":"10.1016\/bs.pmbts.2019.03.005_bb0065","first-page":"59","article-title":"Adverse reactions of aminoglycoside antibiotics","volume":"2","author":"Wang","year":"2009","journal-title":"J Clin Ration Drug Use"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1872213X13666181228154940","article-title":"Urinary tract infection in children","volume":"13","author":"Leung","year":"2019","journal-title":"Recent Patents Inflamm Allergy Drug Discov"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0075","doi-asserted-by":"crossref","first-page":"9429","DOI":"10.12659\/MSM.913205","article-title":"Establishment of a gentamicin cochlear poisoning model in guinea pigs and cochlear nerve endings recognition of ultrasound signals","volume":"24","author":"Wang","year":"2018","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.03.005_bb0080","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/coa.12865","article-title":"Vestibulotoxicity with systemic gentamicin in different dosing regimens: our experience in 46 patients","volume":"42","author":"Syed","year":"2017","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fncel.2016.00083","article-title":"Natural bizbenzoquinoline derivatives protect zebrafish lateral line sensory hair cells from aminoglycoside toxicity","volume":"10","author":"Kruger","year":"2016","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.03.005_bb0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/14787210.2014.878648","article-title":"Aminoglycoside toxicity in neonates: something to worry about?","volume":"12","author":"Kent","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.03.005_bb0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/microorganisms5030035","article-title":"Free and nanoencapsulated tobramycin: effects on planktonic and biofilm forms of pseudomonas","volume":"5","author":"Sans-Serramitjana","year":"2017","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.03.005_bb0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1753465817691239","article-title":"Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence","volume":"11","author":"Hamed","year":"2017","journal-title":"Ther Adv Respir Dis"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.03.005_bb0105","first-page":"482","article-title":"Levofloxacin and tobramycin for severe bacterial keratouveitis","volume":"24","author":"Accorinti","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.03.005_bb0110","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/0897190014546836","article-title":"Aminoglycoside-induced nephrotoxicity","volume":"27","author":"Wargo","year":"2014","journal-title":"J Pharm Pract"},{"issue":"02","key":"10.1016\/bs.pmbts.2019.03.005_bb0115","first-page":"104","article-title":"Clinical analysis of atomization inhalation of ribostamycin in treatment of children with respiration tract infection","volume":"3","author":"Zeng","year":"2018","journal-title":"Syst Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0120","first-page":"184","article-title":"Antibacterial activity of ribostamycin on enterobacteriaceae","volume":"26","author":"Yourassowsky","year":"1976","journal-title":"Arzneimittelforschung"},{"issue":"7\u20138","key":"10.1016\/bs.pmbts.2019.03.005_bb0125","first-page":"284","article-title":"Ribostamycin use in otomastoiditis","volume":"64","author":"Colletti","year":"1983","journal-title":"G Clin Med"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0130","first-page":"279","article-title":"Ribostamycin in chronic and recurrent bronchopulmonary and urinary infections","volume":"71","author":"Abate","year":"1980","journal-title":"Minerva Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40262-016-0428-x","article-title":"Amikacin in critically ill patients: a review of population pharmacokinetic studies","volume":"56","author":"Marsot","year":"2017","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.03.005_bb0140","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/bja\/50.2.109","article-title":"Some effects of the aminoglycoside antibiotic amikacin on neuromuscular and autonomic transmission","volume":"50","author":"Singh","year":"1978","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0150","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1503\/cmaj.140339","article-title":"Aminoglycoside-induced ototoxicity","volume":"187","author":"Leis","year":"2015","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0155","first-page":"45","article-title":"Neuromuscular blocking activity of aminoglycoside antibiotics","volume":"2","author":"Paradelis","year":"1980","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.03.005_bb0160","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1093\/jac\/dkw250","article-title":"Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review","volume":"71","author":"Jenkins","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.03.005_bb0165","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3109\/15563650903438566","article-title":"2008 Annual report of the american association of poison control centers' national poison data system (npds): 26th annual report","volume":"47","author":"Bronstein","year":"2009","journal-title":"Clin Toxicol (Phila)"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.03.005_bb0170","first-page":"163","article-title":"Clinical application of aminoglycoside antibiotics","volume":"23","author":"Liu","year":"2011","journal-title":"Strait Pharm J"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0175","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrmicro3155","article-title":"Ribosome-targeting antibiotics and mechanisms of bacterial resistance","volume":"12","author":"Wilson","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0180","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/CMR.00043-12","article-title":"Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance","volume":"25","author":"Fernandez","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0185","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0006-2952(80)90382-2","article-title":"Ototoxicity of aminoglycosides correlated with their action on monomolecular films of polyphosphoinositides","volume":"29","author":"Lodhi","year":"1980","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0190","first-page":"520","article-title":"Clinical forum: a review of intratympanic therapy","volume":"18","author":"Blakley","year":"1997","journal-title":"Am J Otolaryngol"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/20786190.2014.1002220","article-title":"Aminoglycoside-induced hearing deficits\u2014a review of cochlear ototoxicity","volume":"57","author":"Petersen","year":"2015","journal-title":"S Afr Fam Pract"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.03.005_bb0200","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1445-5994.2011.02452.x","article-title":"Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity","volume":"41","author":"Avent","year":"2011","journal-title":"Intern Med J"},{"issue":"07","key":"10.1016\/bs.pmbts.2019.03.005_bb0205","first-page":"322","article-title":"The development process of aminoglycosides","volume":"32","author":"Zhu","year":"2011","journal-title":"Shanghai Med Pharm J"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.03.005_bb0210","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.7164\/antibiotics.41.1711","article-title":"Nucleoside antibiotics: structure, biological activity, and biosynthesis","volume":"41","author":"Isono","year":"1988","journal-title":"J Antibiot"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.03.005_bb0215","first-page":"806","article-title":"Recent research and development of nucleoside analogues as antimetabolite agents","volume":"29","author":"Zhang","year":"2010","journal-title":"Chin J New Drugs Clin Rem"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0220","series-title":"Pharmacochemistry","author":"Zheng","year":"2007"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0225","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/cncr.21543","article-title":"High-dose cytosine arabinoside in the treatment of acute myeloid leukemia: review of three randomized trials","volume":"107","author":"Kern","year":"2006","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.03.005_bb0230","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.11068","article-title":"Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results","volume":"92","author":"Pigneux","year":"2007","journal-title":"Haematologica"},{"issue":"03","key":"10.1016\/bs.pmbts.2019.03.005_bb0235","first-page":"396","article-title":"Efficacy and safety analysis of cytarine in the treatment of leukemia patients","volume":"8","author":"Ma","year":"2018","journal-title":"Anti Tumor Pharm"},{"issue":"85","key":"10.1016\/bs.pmbts.2019.03.005_bb0240","first-page":"216","article-title":"Observation and nursing practice of adverse reactions of high dose cytarabine in consolidation treatment of children's leukemia","volume":"18","author":"Cao","year":"2018","journal-title":"World Latest Med Inf"},{"issue":"03","key":"10.1016\/bs.pmbts.2019.03.005_bb0245","first-page":"42","article-title":"Analysis of the efficacy and adverse effects of high-dose cytarabine in the treatment of adult acute myelogenous leukemia","volume":"34","author":"Diao","year":"2018","journal-title":"J Shanxi Datong Univ"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0250","first-page":"4726451","article-title":"Prevention of high-dose cytosine arabinoside-induced acute pericarditis with preemptive dexamethasone administration: a case report and literature review","volume":"2018","author":"Owattanapanich","year":"2018","journal-title":"Case Rep Hematol"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2019.03.005_bb0255","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.2459\/JCM.0b013e328341d0e5","article-title":"High-dose cytosine arabinoside-induced symptomatic bradycardia","volume":"16","author":"Wayangankar","year":"2015","journal-title":"J Cardiovasc Med"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.03.005_bb0260","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.healun.2015.01.009","article-title":"Oral ribavirin for respiratory syncytial virus infection after lung transplantation: efficacy and cost-efficiency","volume":"34","author":"Burrows","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.03.005_bb0265","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jac\/dkr136","article-title":"Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis","volume":"66","author":"Ascioglu","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.03.005_bb0270","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/657315","article-title":"Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever","volume":"51","author":"Bausch","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0275","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/liv.13212","article-title":"Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection","volume":"37","author":"Feld","year":"2017","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.03.005_bb0280","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0285","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2017.09.002","article-title":"DHEA prevents ribavirin-induced anemia via inhibition of glucose-6-phosphate dehydrogenase","volume":"146","author":"Handala","year":"2017","journal-title":"Antivir Res"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.03.005_bb0290","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jvp.12394","article-title":"Hematological adverse effects and pharmacokinetics of ribavirin in pigs following intramuscular administration","volume":"40","author":"Lee","year":"2017","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0295","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2015.04.006","article-title":"Common adverse events associated with ribavirin therapy for severe fever with thrombocytopenia syndrome","volume":"119","author":"Lu","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0300","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.biopha.2016.10.030","article-title":"Plant-derived cardiac glycosides: role in heart ailments and cancer management","volume":"84","author":"Patel","year":"2016","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.03.005_bb0305","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/bcr2205","article-title":"Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study","volume":"10","author":"Ahern","year":"2008","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2010.02.137","article-title":"Medicinal plants and antioxidants: what do we learn from cell culture and Caenorhabditis elegans studies?","volume":"394","author":"Tang","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0315","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jep.2014.06.025","article-title":"Antiproliferative activity and new argininyl bufadienolide esters from the \u201ccururu\u201d toad Rhinella (Bufo) schneideri","volume":"155","author":"Schmeda-Hirschmann","year":"2014","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0320","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/50100051","article-title":"Melero* MMaASF. A short review on cardiotonic steroids and their aminoguanidine analogues","volume":"5","author":"Concepci\u00f3n","year":"2000","journal-title":"Molecules"},{"issue":"02","key":"10.1016\/bs.pmbts.2019.03.005_bb0325","first-page":"108","article-title":"Digitalis drugs and clinic","volume":"4","author":"Liu","year":"2010","journal-title":"Chin J Mod Drug Appl"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0330","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3892\/mmr.2016.6096","article-title":"Digitoxin synergizes with sorafenib to inhibit hepatocelluar carcinoma cell growth without inhibiting cell migration","volume":"15","author":"Xiao","year":"2017","journal-title":"Mol Med Rep"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0335","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3892\/or.2015.4416","article-title":"Digitoxin and its synthetic analog MonoD have potent antiproliferative effects on lung cancer cells and potentiate the effects of hydroxyurea and paclitaxel","volume":"35","author":"Yakisich","year":"2016","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0340","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2162-3619-1-4","article-title":"Digitoxin and its analogs as novel cancer therapeutics","volume":"1","author":"Elbaz","year":"2012","journal-title":"Exp Hematol Oncol"},{"issue":"1079","key":"10.1016\/bs.pmbts.2019.03.005_bb0345","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/postgradmedj-2014-132937","article-title":"Digoxin: its role in contemporary medicine","volume":"91","author":"Stucky","year":"2015","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0350","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/0897190016642361","article-title":"Role of digoxin in atrial fibrillation","volume":"30","author":"Scalese","year":"2017","journal-title":"J Pharm Pract"},{"issue":"28","key":"10.1016\/bs.pmbts.2019.03.005_bb0355","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/eurheartj\/ehv143","article-title":"Digoxin-associated mortality: a systematic review and meta-analysis of the literature","volume":"36","author":"Vamos","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.03.005_bb0360","first-page":"35","article-title":"The effect of lincomycin on prevention of infection in patients with open fracture","volume":"15","author":"Qi","year":"2018","journal-title":"J North Pharm"},{"issue":"09","key":"10.1016\/bs.pmbts.2019.03.005_bb0365","first-page":"557","article-title":"Literature analysis of 241 cases of adverse drug reactions induced by lincomycin","volume":"10","author":"Chen","year":"2013","journal-title":"Chin J Pharma"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.03.005_bb0370","first-page":"154","article-title":"Clindamycin in the treatment of mycoplasma pneumonia in children","volume":"28","author":"Huang","year":"2016","journal-title":"Strait Pharma J"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.03.005_bb0375","doi-asserted-by":"crossref","first-page":"e013260","DOI":"10.1136\/bmjopen-2016-013260","article-title":"Adjunctive clindamycin for cellulitis: a clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis","volume":"7","author":"Brindle","year":"2017","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.03.005_bb0380","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa1403789","article-title":"Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections","volume":"372","author":"Miller","year":"2015","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/bs.pmbts.2019.03.005_bb0385","first-page":"1269","article-title":"Adverse effects of Clindamycin injection: a meta-analysis","volume":"39","author":"Pan","year":"2017","journal-title":"Zhejiang Med J"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0390","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/jcpt.12528","article-title":"Clindamycin-associated acute generalized exanthematous pustulosis","volume":"42","author":"Croy","year":"2017","journal-title":"J Clin Pharm Ther"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.03.005_bb0395","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2169\/internalmedicine.55.6084","article-title":"Clindamycin-induced kidney diseases: a retrospective analysis of 50 patients","volume":"55","author":"Wan","year":"2016","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.03.005_bb0400","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s15010-015-0826-2","article-title":"Clindamycin-induced hypersensitivity reaction","volume":"44","author":"Bulloch","year":"2016","journal-title":"Infection"},{"issue":"37","key":"10.1016\/bs.pmbts.2019.03.005_bb0405","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004790","article-title":"Treatment of deep-seated facial microcystic lymphatic malformations with intralesional injection of pingyangmycin","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.03.005_bb0410","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/np9005212","article-title":"Cardiac glycosides from Antiaris toxicaria with potent cardiotonic activity","volume":"73","author":"Shi","year":"2010","journal-title":"J Nat Prod"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.03.005_bb0415","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nrd2682","article-title":"Novel therapeutic applications of cardiac glycosides","volume":"7","author":"Prassas","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.03.005_bb0420","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1158\/0008-5472.CAN-05-3544","article-title":"Cardiac glycosides initiate Apo2L\/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5","volume":"66","author":"Frese","year":"2006","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/bs.pmbts.2019.03.005_bb0425","first-page":"2032","article-title":"Advances in anti-tumor effect of cardiac glycoside","volume":"17","author":"Chen","year":"2011","journal-title":"Med Recap"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.03.005_bb0430","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/jcp.25611","article-title":"Anti-tumor effects of cardiac glycosides on human lung cancer cells and lung tumorspheres","volume":"232","author":"Kaushik","year":"2017","journal-title":"J Cell Physiol"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0435","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ccc.2012.07.005","article-title":"Cardiac glycoside toxicity: more than 200 years and counting","volume":"28","author":"Kanji","year":"2012","journal-title":"Crit Care Clin"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0440","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.phytochem.2012.02.005","article-title":"Glucosinolate structures in evolution","volume":"77","author":"Agerbirk","year":"2012","journal-title":"Phytochemistry"},{"issue":"17","key":"10.1016\/bs.pmbts.2019.03.005_bb0445","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.carres.2006.09.021","article-title":"Three 1-thio-beta-D-glucopyranosides from the seeds of Afrostyrax lepidophyllus Mildbr","volume":"341","author":"Ngane","year":"2006","journal-title":"Carbohydr Res"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0450","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.carres.2009.11.020","article-title":"Synthesis of raphanuside, an unusual oxathiane-fused thioglucoside isolated from the seeds of Raphanus sativus L","volume":"345","author":"Yang","year":"2010","journal-title":"Carbohydr Res"},{"issue":"21","key":"10.1016\/bs.pmbts.2019.03.005_bb0455","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1021\/ja1014037","article-title":"A biosynthetic pathway for BE-7585A, a 2-thiosugar-containing angucycline-type natural product","volume":"132","author":"Sasaki","year":"2010","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0460","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejmech.2010.11.008","article-title":"Synthesis and in vitro anti-tumor activity of new oxadiazole thioglycosides","volume":"46","author":"Abu-Zaied","year":"2011","journal-title":"Eur J Med Chem"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.03.005_bb0465","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.bmcl.2009.12.017","article-title":"Synthesis and structure-activity relationships of novel furazan-3,4-diamide analogs as potent anti-cancer agents","volume":"20","author":"Li","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"18","key":"10.1016\/bs.pmbts.2019.03.005_bb0470","first-page":"110","article-title":"Erythromycin combined with azithromycin in the treatment of mycoplasma pneumoniae pneumonia in children","volume":"16","author":"Wang","year":"2018","journal-title":"Contemp Med Symp"},{"issue":"59","key":"10.1016\/bs.pmbts.2019.03.005_bb0475","first-page":"130","article-title":"Therapeutic effect of erythromycin combined with aerosol inhalation on elderly asthma patients","volume":"18","author":"Luo","year":"2018","journal-title":"World Latest Med Inf"},{"issue":"22","key":"10.1016\/bs.pmbts.2019.03.005_bb0480","first-page":"35","article-title":"The clinical effect of erythromycin in the treatment of neonatal gastrointestinal dysfunction","volume":"34","author":"Feng","year":"2018","journal-title":"Chin Community Doct"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.03.005_bb0485","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00228-013-1624-3","article-title":"Fetal safety of erythromycin. An update of Swedish data","volume":"70","author":"Kallen","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"19","key":"10.1016\/bs.pmbts.2019.03.005_bb0490","first-page":"70","article-title":"Efficacy and adverse reactions of oral azithromycin, oral and intravenous erythromycin in the treatment of respiratory mycoplasma infection","volume":"3","author":"AI","year":"2018","journal-title":"Syst Med"},{"issue":"02","key":"10.1016\/bs.pmbts.2019.03.005_bb0495","first-page":"166","article-title":"Research advances in cardiac safety of erythromycin","volume":"25","author":"Zhang","year":"2018","journal-title":"Pharm Biotechnol"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0500","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.yexcr.2016.08.024","article-title":"Roxithromycin inhibits VEGF-induced human airway smooth muscle cell proliferation: opportunities for the treatment of asthma","volume":"347","author":"Pei","year":"2016","journal-title":"Exp Cell Res"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.03.005_bb0505","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1177\/1535370215591829","article-title":"Roxithromycin inhibits nuclear factor kappaB signaling and endoplasmic reticulum stress in intestinal epithelial cells and ameliorates experimental colitis in mice","volume":"240","author":"Choi","year":"2015","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.msec.2015.11.076","article-title":"Characterization and application of roxithromycin loaded cyclodextrin based nanoparticles for treatment of multidrug resistant bacteria","volume":"61","author":"Masood","year":"2016","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"07","key":"10.1016\/bs.pmbts.2019.03.005_bb0515","first-page":"87","article-title":"Exploration of adverse reactions caused by roxithromycin in clinic","volume":"16","author":"Ren","year":"2018","journal-title":"Guide of China Med"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0520","first-page":"1","article-title":"Azithromycin","volume":"vol. 39","author":"Bakheit","year":"2014"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2019.03.005_bb0525","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000481224","article-title":"Comparative study of clarithromycin- versus metronidazole-based triple therapy as first-line eradication for helicobacter pylori","volume":"93","author":"Adachi","year":"2017","journal-title":"Oncology"},{"issue":"15","key":"10.1016\/bs.pmbts.2019.03.005_bb0530","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.3748\/wjg.v20.i15.4362","article-title":"Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan","volume":"20","author":"Nishida","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"79","key":"10.1016\/bs.pmbts.2019.03.005_bb0535","first-page":"123","article-title":"Analysis of adverse reactions of dierythromycin, clarithromycin and azithromycin","volume":"18","author":"Chen","year":"2018","journal-title":"World Latest Med Inf"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.03.005_bb0540","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5578\/mb.7748","article-title":"Macrolide-lincosamide-streptogramin B (MLSB) resistance phenotypes in clinical Staphylococcus isolates and investigation of telithromycin activity","volume":"48","author":"Uzun","year":"2014","journal-title":"Mikrobiyol Bul"},{"issue":"154","key":"10.1016\/bs.pmbts.2019.03.005_bb0545","first-page":"264","article-title":"Telithromycin: review of adverse effects","volume":"23","author":"Prescrire Editorial Staff","year":"2014","journal-title":"Prescrire Int"},{"issue":"13","key":"10.1016\/bs.pmbts.2019.03.005_bb0550","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa0901409","article-title":"High-dose daunorubicin in older patients with acute myeloid leukemia","volume":"361","author":"Lowenberg","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0555","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3892\/mmr.2017.6554","article-title":"Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia","volume":"16","author":"Du","year":"2017","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0560","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/mol.114.093849","article-title":"Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2A","volume":"86","author":"Hanna","year":"2014","journal-title":"Mol Pharmacol"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.03.005_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133569","article-title":"Efficacy and cardiotoxicity of liposomal doxorubicin-based chemotherapy in advanced breast cancer: a meta-analysis of ten randomized controlled trials","volume":"10","author":"Xing","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.03.005_bb0570","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","article-title":"Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management","volume":"49","author":"Takemura","year":"2007","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0575","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.biopha.2017.09.059","article-title":"A review on the efficacy and toxicity of different doxorubicin nanoparticles for targeted therapy in metastatic breast cancer","volume":"95","author":"Shafei","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0580","first-page":"618","article-title":"Methotrexate and epirubicin conjugates as potential antitumor drugs","volume":"71","author":"Kmiecik","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0585","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.critrevonc.2016.04.001","article-title":"Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: a systematic review and meta-analysis","volume":"102","author":"Petrioli","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.03.005_bb0590","doi-asserted-by":"crossref","first-page":"12301","DOI":"10.1007\/s13277-016-5088-9","article-title":"Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer","volume":"37","author":"Wu","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0595","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.toxlet.2017.06.006","article-title":"Aclarubicin, an anthracycline anti-cancer drug, fluorescently contrasts mitochondria and reduces the oxygen consumption rate in living human cells","volume":"277","author":"Iihoshi","year":"2017","journal-title":"Toxicol Lett"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0600","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.leukres.2015.12.013","article-title":"A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: a propensity score analysis","volume":"42","author":"Minakata","year":"2016","journal-title":"Leuk Res"},{"issue":"02","key":"10.1016\/bs.pmbts.2019.03.005_bb0605","first-page":"184","article-title":"Arubicin combined with medium dose cytarabine induction therapy for refractory and recurrent acute myeloid leukemia","volume":"29","author":"Liu","year":"2009","journal-title":"Tumour"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0610","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1432-1033.1987.tb10991.x","article-title":"Inhibition of ribosomal peptidyltransferase by chloramphenicol. Kinetic studies","volume":"164","author":"Drainas","year":"1987","journal-title":"Eur J Biochem"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0615","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF03256601","article-title":"Diffuse panbronchiolitis: role of macrolides in therapy","volume":"1","author":"Keicho","year":"2002","journal-title":"Am J Respir Med"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.03.005_bb0620","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.coph.2008.01.010","article-title":"Macrolides as immunomodulatory medications for the therapy of chronic lung diseases","volume":"8","author":"Lopez-Boado","year":"2008","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0625","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/dkh309","article-title":"Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis","volume":"54","author":"Schultz","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0630","doi-asserted-by":"crossref","first-page":"a2286","DOI":"10.1136\/bmj.a2286","article-title":"Statin induced myopathy","volume":"337","author":"Sathasivam","year":"2008","journal-title":"BMJ"},{"issue":"3\u20134","key":"10.1016\/bs.pmbts.2019.03.005_bb0635","first-page":"290","article-title":"Hepatotoxicity of antibiotics","volume":"58","author":"Hautekeete","year":"1995","journal-title":"Acta Gastroenterol Belg"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0640","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0022-3468(76)90283-9","article-title":"Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: a report of five cases","volume":"11","author":"SanFilippo","year":"1976","journal-title":"J Pediatr Surg"},{"issue":"9196","key":"10.1016\/bs.pmbts.2019.03.005_bb0645","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0140-6736(99)10073-4","article-title":"Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study","volume":"354","author":"Honein","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0650","first-page":"1","article-title":"Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis","author":"Abdellatif","year":"2018","journal-title":"Eur J Pediatr"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2019.03.005_bb0655","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ejps.2012.10.027","article-title":"Anti-inflammatory properties of anthraquinones and their relationship with the regulation of P-glycoprotein function and expression","volume":"48","author":"Choi","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0660","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/bies.20160","article-title":"The anthracycline antibiotics: antitumor drugs that alter chromatin structure","volume":"27","author":"Rabbani","year":"2005","journal-title":"Bioessays"},{"issue":"03","key":"10.1016\/bs.pmbts.2019.03.005_bb0665","first-page":"161","article-title":"Advances on biosynthesis of anthracycline antibiotics by streptomyces peucetius","volume":"36","author":"He","year":"2011","journal-title":"Chin J Antibiot"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0670","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000261977","article-title":"Effect of sugar alcohols on the composition and metabolism of a mixed culture of oral bacteria grown in a chemostat","volume":"28","author":"Bradshaw","year":"1994","journal-title":"Caries Res"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.03.005_bb0675","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1159\/000358399","article-title":"Effect of erythritol and xylitol on dental caries prevention in children","volume":"48","author":"Honkala","year":"2014","journal-title":"Caries Res"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.03.005_bb0680","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000052818","article-title":"Increased bone volume and bone mineral content in xylitol-fed aged rats","volume":"47","author":"Mattila","year":"2001","journal-title":"Gerontology"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0685","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10266-010-0143-2","article-title":"The effects of oral xylitol administration on bone density in rat femur","volume":"99","author":"Sato","year":"2011","journal-title":"Odontology"},{"issue":"17","key":"10.1016\/bs.pmbts.2019.03.005_bb0690","first-page":"2","article-title":"Application of mannitol in clinic","volume":"5","author":"Zhong","year":"2017","journal-title":"Cardiovasc Dis J Integr Tradit Chin West Med"},{"issue":"06","key":"10.1016\/bs.pmbts.2019.03.005_bb0695","first-page":"364","article-title":"Analysis on 137 cases of adverse drug reactions of mannitol injection","volume":"13","author":"Zhang","year":"2016","journal-title":"Chin J Pharm"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0700","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1139\/apnm-2016-0433","article-title":"Sorbitol increases muscle glucose uptake ex vivo and inhibits intestinal glucose absorption ex vivo and in normal and type 2 diabetic rats","volume":"42","author":"Chukwuma","year":"2017","journal-title":"Appl. Physiol. Nutr. Metab."},{"issue":"3","key":"10.1016\/bs.pmbts.2019.03.005_bb0705","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1039\/C4FO00994K","article-title":"Effects of xylitol on carbohydrate digesting enzymes activity, intestinal glucose absorption and muscle glucose uptake: a multi-mode study","volume":"6","author":"Chukwuma","year":"2015","journal-title":"Food Funct"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.03.005_bb0710","doi-asserted-by":"crossref","first-page":"H1436","DOI":"10.1111\/1750-3841.12520","article-title":"Xylitol improves pancreatic islets morphology to ameliorate type 2 diabetes in rats: a dose response study","volume":"79","author":"Rahman","year":"2014","journal-title":"J Food Sci"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0715","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2334\/josnusd.17-0446","article-title":"Effects of xylitol-containing chewing gum on the oral microbiota","volume":"60","author":"Takeuchi","year":"2018","journal-title":"J Oral Sci"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0720","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.micpath.2018.06.038","article-title":"Coupling xylitol with remineralizing agents improves tooth protection against demineralization but reduces antibiofilm effect","volume":"123","author":"Gargouri","year":"2018","journal-title":"Microb Pathog"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.03.005_bb0725","doi-asserted-by":"crossref","first-page":"e020941","DOI":"10.1136\/bmjopen-2017-020941","article-title":"Xylitol for the prevention of acute otitis media episodes in children aged 2\u20134 years: protocol for a pragmatic randomised controlled trial","volume":"8","author":"Persaud","year":"2018","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.03.005_bb0730","first-page":"680","article-title":"Clinical application and potential risk analysis of xylitol-containing injections","volume":"14","author":"Xu","year":"2017","journal-title":"Chin J Pharm"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0735","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.03.005_bb0740","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00277-014-2108-y","article-title":"Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the infectious diseases working party of the German society for haematology and oncology","volume":"93","author":"Tacke","year":"2014","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.03.005_bb0745","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/jphp.12802","article-title":"Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis","volume":"69","author":"Tonin","year":"2017","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.03.005_bb0750","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/myc.12585","article-title":"Efficacy and safety of amphotericin B lipid-based formulations-a systematic review and meta-analysis","volume":"60","author":"Steimbach","year":"2017","journal-title":"Mycoses"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.03.005_bb0755","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1128\/AAC.01698-15","article-title":"Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis","volume":"59","author":"Bicanic","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0760","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0019-509X.98933","article-title":"A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India","volume":"49","author":"Jadhav","year":"2012","journal-title":"Indian J Cancer"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0765","first-page":"224","article-title":"Adverse reactions of nystatin in the treatment of children thrush","volume":"04","author":"Wang","year":"2016","journal-title":"Biotech World"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.03.005_bb0770","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12866-018-1316-3","article-title":"Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Microbiol"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0775","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/10837450.2016.1221424","article-title":"Nystatin and lidocaine pastilles for the local treatment of oral mucositis","volume":"22","author":"Silva","year":"2017","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0780","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2147\/DDDT.S100795","article-title":"Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis","volume":"10","author":"Lyu","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0785","first-page":"58","article-title":"Clinical application and adverse reactions of nystatin","volume":"01","author":"Wang","year":"2001","journal-title":"China Pharm"},{"issue":"19","key":"10.1016\/bs.pmbts.2019.03.005_bb0790","first-page":"4424","article-title":"Clinical study of norvancomycin in the treatment of lung infections of critical patients caused by ethicillin-resistant Staphylococcus aureus","volume":"25","author":"Jin","year":"2015","journal-title":"Chin J Nosocomiol"},{"issue":"03","key":"10.1016\/bs.pmbts.2019.03.005_bb0795","first-page":"76","article-title":"Clinical pharmaceutical analysis of leukopenia induced by vancomycin and norvancomycin","volume":"10","author":"Zhou","year":"2017","journal-title":"Chin J Clin Ration Drug Use"},{"issue":"15","key":"10.1016\/bs.pmbts.2019.03.005_bb0800","first-page":"1440","article-title":"Erythema multiforme eruption produced by norvancomycin: 1 case","volume":"35","author":"Luo","year":"2015","journal-title":"Chin J Hosp Pharm"},{"issue":"05","key":"10.1016\/bs.pmbts.2019.03.005_bb0805","first-page":"53","article-title":"One case of severe exfoliative dermatitis caused by norvancomycin","volume":"11","author":"Liu","year":"2014","journal-title":"China Licensed Pharm"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.03.005_bb0810","doi-asserted-by":"crossref","first-page":"15952","DOI":"10.18632\/oncotarget.15021","article-title":"Safety and efficacy of bleomycin\/pingyangmycin-containing chemotherapy regimens for malignant germ cell tumor patients in the female genital system","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"issue":"07","key":"10.1016\/bs.pmbts.2019.03.005_bb0815","first-page":"36","article-title":"Analysis of 1 cases of allergic shock induced by injection of Pingyang hydrochloride","volume":"14","author":"Cai","year":"2016","journal-title":"J China Prescription Drug"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0820","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.12659\/MSM.911979","article-title":"Metformin or acarbose treatment significantly reduced albuminuria in patients with newly diagnosed type 2 diabetes mellitus and low-grade albuminuria","volume":"24","author":"Pan","year":"2018","journal-title":"Med Sci Monit"},{"issue":"14","key":"10.1016\/bs.pmbts.2019.03.005_bb0825","first-page":"55","article-title":"Clinical effect and adverse reactions of acarbose in the treatment of type 2 diabetes mellitus","volume":"4","author":"Han","year":"2017","journal-title":"J Pract Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0830","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/jvim.15076","article-title":"Effect of sucralfate on gastric permeability in an ex vivo model of stress-related mucosal disease in dogs","volume":"32","author":"Hill","year":"2018","journal-title":"J Vet Intern Med"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.03.005_bb0835","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/01635581.2016.1153666","article-title":"Efficacy of sucralfate mouth wash in prevention of 5-fluorouracil induced oral mucositis: a prospective, randomized, double-blind, controlled trial","volume":"68","author":"Ala","year":"2016","journal-title":"Nutr Cancer"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0840","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/codi.12507","article-title":"Sucralfate paste enema: a new method of topical treatment for haemorrhagic radiation proctitis","volume":"16","author":"McElvanna","year":"2014","journal-title":"Colorectal Dis"},{"issue":"02","key":"10.1016\/bs.pmbts.2019.03.005_bb0845","first-page":"130","article-title":"Adverse reactions and clinical application of sucralfate and aluminum","volume":"4","author":"Li","year":"2010","journal-title":"Chin J Mod Drug Appl"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.03.005_bb0850","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00198-014-2965-1","article-title":"Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy","volume":"26","author":"Krause","year":"2015","journal-title":"Osteoporos Int"},{"issue":"06","key":"10.1016\/bs.pmbts.2019.03.005_bb0855","first-page":"620","article-title":"the effect of oral calcium gluconate on serum calcium magnesium and parathyroid hormone levels in donors during plateletpheresis","volume":"31","author":"Ye","year":"2018","journal-title":"Chin J Blood Trans"},{"issue":"04","key":"10.1016\/bs.pmbts.2019.03.005_bb0860","first-page":"275","article-title":"Analysis of adverse reaction reports of calcium gluconate injection","volume":"26","author":"Zhang","year":"2017","journal-title":"Chin J Pharm"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0865","first-page":"1048","article-title":"Effect of zinc gluconate on children's persistent diarrhea and immune function","volume":"09","author":"Ye","year":"2018","journal-title":"J Ningxia Med Univ"},{"issue":"18","key":"10.1016\/bs.pmbts.2019.03.005_bb0870","first-page":"55","article-title":"Observation on the effect of zinc gluconate in the treatment of zinc deficiency anorexia in children","volume":"4","author":"Tan","year":"2018","journal-title":"Smart Healthcare"},{"issue":"06","key":"10.1016\/bs.pmbts.2019.03.005_bb0875","first-page":"446","article-title":"Observation on the efficacy of zinc gluconate tablets in the treatment of recurrent upper respiratory tract infections in children","volume":"27","author":"Guo","year":"2018","journal-title":"Proc Clin Med"},{"key":"10.1016\/bs.pmbts.2019.03.005_bb0880","first-page":"643","article-title":"Clinical application and adverse reactions of zinc gluconate","volume":"11","author":"Hao","year":"1989","journal-title":"Chin Pharm J"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.03.005_bb0885","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163047","article-title":"A comparison of the effectiveness of sodium stibogluconate monotherapy to sodium stibogluconate and paromomycin combination for the treatment of severe post Kala Azar dermal leishmaniasis in South Sudan\u2014a retrospective cohort study","volume":"11","author":"Abongomera","year":"2016","journal-title":"PLoS One"},{"issue":"suppl 5","key":"10.1016\/bs.pmbts.2019.03.005_bb0890","first-page":"S3","article-title":"AmBisome targeting to fungal infections","volume":"14","author":"Adler-Moore","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.03.005_bb0895","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1128\/AAC.01586-09","article-title":"Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosis","volume":"54","author":"Lestner","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0900","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0005-2736(82)90103-1","article-title":"Equilibrium binding of amphotericin B and its methyl ester and borate complex to sterols","volume":"685","author":"Readio","year":"1982","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0905","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2009.09.019","article-title":"Temperature-dependent transfer of amphotericin B from liposomal membrane of AmBisome to fungal cell membrane","volume":"141","author":"Shimizu","year":"2010","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.03.005_bb0910","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/AAC.42.2.263","article-title":"Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats","volume":"42","author":"Boswell","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.03.005_bb0915","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1023\/A:1018997730462","article-title":"Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome) in beagle dogs","volume":"16","author":"Bekersky","year":"1999","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.03.005_bb0920","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2008.09.038","article-title":"Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death","volume":"135","author":"Kohanski","year":"2008","journal-title":"Cell"},{"issue":"18","key":"10.1016\/bs.pmbts.2019.03.005_bb0925","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1128\/JB.05133-11","article-title":"Membrane proteases and aminoglycoside antibiotic resistance","volume":"193","author":"Hinz","year":"2011","journal-title":"J Bacteriol"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.03.005_bb0930","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1128\/AAC.00885-15","article-title":"Inhibition of aminoglycoside acetyltransferase resistance enzymes by metal salts","volume":"59","author":"Li","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Progress in Molecular Biology and Translational Science","Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117319300390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117319300390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T04:29:23Z","timestamp":1721104163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117319300390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128177402"],"references-count":185,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2019.03.005","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}